Alpha Tau Medical (DRTS)
(Delayed Data from NSDQ)
$2.29 USD
+0.01 (0.44%)
Updated Nov 6, 2024 02:38 PM ET
After-Market: $2.28 -0.01 (-0.44%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Alpha Tau Medical Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 36 | 32 | 14 | 0 | 8 |
Income After Depreciation & Amortization | -36 | -32 | -14 | 0 | -8 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | -7 | 2 | 13 | 0 | 0 |
Pretax Income | -29 | -34 | -27 | 0 | -8 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -29 | -34 | -27 | 0 | -8 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -29 | -34 | -27 | 0 | -8 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -35 | -31 | -13 | 0 | -8 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -36 | -32 | -14 | 0 | -8 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 69.38 | 63.54 | 40.54 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.42 | -0.53 | -0.34 | NA | NA |
Diluted Net EPS (GAAP) | -0.42 | -0.53 | -0.67 | NA | NA |
Fiscal Year end for Alpha Tau Medical Ltd falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | NA | NA | 0.00 | NA | NA |
Gross Profit | NA | NA | 0.00 | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 8.43 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | -8.43 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | 0.44 | NA | NA |
Interest Expense | NA | NA | 0.00 | NA | NA |
Pretax Income | NA | NA | -7.98 | NA | NA |
Income Taxes | NA | NA | 0.00 | NA | NA |
Minority Interest | NA | NA | 0.00 | NA | NA |
Investment Gains/Losses | NA | NA | 0.00 | NA | NA |
Other Income/Charges | NA | NA | 0.00 | NA | NA |
Income From Cont. Operations | NA | -7.37 | -7.98 | -7.37 | -4.91 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -7.37 | -7.98 | -7.37 | -4.91 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 66.99 | 69.71 | 66.95 | 69.32 |
Diluted EPS Before Non-Recurring Items | NA | -0.11 | -0.11 | -0.11 | -0.07 |
Diluted Net EPS (GAAP) | NA | -0.11 | -0.11 | -0.11 | -0.07 |